Mutations in TET2, IDH2, and DNMT3A are frequently seen in AITL and AITL-like PTCL-NOS [8], [9], although these mutations are also common to various myeloid malignancies [10], [11]. This evidence concerns the gene TET2 and angioimmunoblastic T-cell lymphoma.